Tekmira Pharmaceuticals has appointed Mark Kowalski as its chief medical officer.
Before joining Tekmira, he was chief medical officer of YM BioSciences. He joined Gilead Sciences following its acquisition of YM.
Tekmira also disclosed that its CFO Ian Mortimer will leave the company Oct. 15. He has been with Tekmira for five years.
The search for a new CFO is underway.